Reference-Based Pricing and Balance-Billing Exposure in Self-Funded Health Plans for 2026

For a self-funded employer, every health-plan dollar is the employer’s own, which makes the price paid for care the plan’s central question. Reference-based pricing answers it differently than the network model most employers inherit. Rather than negotiating a discount off a hospital’s list price — a chargemaster figure that bears little relationship to cost — a reference-based plan sets reimbursement as a defined multiple of Medicare, commonly 120 to 160 percent, and pays that amount regardless of what the provider bills. The reference is objective and public; the discount off an inflated charge is neither.

The appeal in 2026 is a function of the trend line. Segal projects a 9 percent median medical cost increase for the year and 11 percent for prescription drugs, the steepest medical projection in more than a decade. Against that backdrop, the gap reference-based pricing targets is large: RAND has found that private plans pay hospitals roughly 240 percent of what Medicare pays for the same services. Employers who reprice against Medicare rather than the chargemaster commonly report claims savings in the range of 20 to 30 percent. For a self-funded plan absorbing double-digit trend, that is not a rounding difference.

The saving carries a specific risk, and it has a name: balance billing. Because a reference-based plan generally operates without a contracted provider network, nothing prevents a hospital from billing the member for the difference between its charge and the plan’s Medicare-based payment. A member who owes that balance — sometimes routed to collections — experiences the plan as a broken promise rather than a saving. The programs that succeed treat member advocacy as core infrastructure: patient-support services that negotiate the balance, defend the member, and resolve the dispute. As one administrator puts it, balance billing is realistically the only barrier, and a program fails when patients have nowhere to turn for help.

Employers sometimes assume federal law closes the gap. It largely does not. The No Surprises Act protects members in three situations — emergency services, out-of-network care delivered at an in-network facility, and out-of-network air ambulance. A reference-based plan, having no facility network, falls outside that middle category for routine care; its surprise-bill protections are effectively limited to emergencies and air ambulance. The routine, non-emergency balance bill — the one a reference-based plan actually generates — is not what the statute was written to stop.

The decision to adopt reference-based pricing is a fiduciary one, and 2026 is a pointed year to remember it. Under ERISA, as sharpened by the Consolidated Appropriations Act of 2021, plan fiduciaries must act prudently and solely in participants’ interest, ensure the fees they pay are reasonable, and document the basis for plan-design decisions. A wave of health-plan fiduciary litigation — the same prudence and fee theories that reshaped retirement plans, now aimed at group health — has made the record behind a plan-design choice matter. Adopting a model that shifts balance-billing risk onto members without a robust advocacy program is precisely the kind of decision a fiduciary should be able to defend.

Reference-based pricing also changes the conversation with the stop-loss carrier. Self-funded plans cap their exposure with specific and aggregate stop-loss, and a carrier confronting an unusually high expected claimant can apply a laser — a higher deductible or an exclusion for that individual — leaving the employer to absorb the gap. Unresolved balance-bill disputes and litigated charges complicate what stop-loss ultimately reimburses, and the interaction has to be modeled before the plan year rather than discovered during it. A reference-based design that ignores its stop-loss treaty can save on claims and lose the saving at the reinsurance layer.

The exposure is not theoretical. In the case widely cited as the first reference-based-pricing lawsuit, a hospital sued a plan member over an eighty-four-thousand-dollar balance after the plan paid a fraction of the billed charge — a reminder of what surfaces when there is no negotiated provider contract behind the payment. For employers who fund their health risk through a captive, reference-based pricing can extend the same ownership logic the captive embodies: control the price, see the data, and manage the exposure deliberately. But it belongs inside a program built to handle balance billing, not bolted onto one that is not.

Our four-step Strategic Process is built to weigh exactly that. Strategic Discovery clarifies what the plan sponsor wants reference-based pricing to accomplish and how much member disruption it can tolerate. Risk Assessment models the savings against the balance-billing, stop-loss, and fiduciary exposures side by side. Solution Design pairs the pricing model with the member-advocacy, stop-loss coordination, and documentation that make it defensible. Ongoing Optimization keeps the program accountable as claims, litigation, and the law continue to move. Reference-based pricing can return real control over the largest variable cost most employers carry — but only to the sponsor who treats the balance bill as a risk to be managed rather than a surprise to be discovered.